Your Article Summary
ORENCIA (abatacept) Demonstrates Consistent Safety and Effectiveness Over 7 Years
Bristol Myers-Squibb Company, 06/18/09
The first, a long-term extension study, analysed ORENCIA's safety and efficacy profile over 7 years of treatment in rheumatoid arthritis patients who have had an inadequate response to methotrexate.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09
Bayer Team wins the “Deutscher Zukunftspreis” awarded by the German President
BayNews International, 12/03/09
GSK Update: GSKs Arepanrix H1N1 pandemic vaccine prequalified by the World Health Organization
GlaxoSmithKline, 12/02/09
Article Search
Sponsor


See Latest Articles


